Building the Campus
Print Version
New Cancer Research Building is Slated for UCSF Mission Bay
The number of talented researchers and innovative research projects within the Cancer Center continues to grow rapidly, and space remains in short supply. To help relieve the space crunch, UCSF plans to build a new cancer research building at its 43-acre Mission Bay campus.
The new building will host Cancer Center researchers who study brain and prostate cancer, as well as members of the Cancer Research Institute and cancer researchers in the population sciences. The Mount Zion campus will continue to be the center for clinical and research programs in lung, breast and skin cancer, while the Parnassus campus will remain the site for leukemia and lymphoma programs.
Researchers already have moved into the first Mission Bay campus research building, Genentech Hall. A building for genetics, development and behavioral sciences research will be completed later this year, and the headquarters for the Institute for Quantitative Biology Biomedical Research also is under construction. A community center and student housing are scheduled. Many more buildings for the site are being planned for the future.
Groundbreaking for the cancer research building is anticipated for May 2004, and the structure is scheduled for occupancy beginning in June 2006. It will house 46 principal investigators, along with their graduate students, postdoctoral fellows, and research support staffs. The building will encompass nearly 162,000 square feet, including 97,000 square feet usable for laboratories, population sciences, informatics and imaging studies. The cancer research building will cost more than $120 million to complete, $85 million of which must be raised from private funds. The additional laboratory space that becomes available will make it possible to hire new Cancer Center researchers.
The building design, envisioned by Rafael Viñoly Architects, can be glimpsed in the drawings on these pages. The design is being finalized and will be submitted for approval to the UC Board of Regents this summer.
Source: Jeffrey Norris (originally appeared in the Spring 2003 issue of the UCSF Cancer Center Report)
Last updated January 28, 2005
|